XML 83 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Long Term Obligations (Tables)
 9 Months Ended
Sep. 30, 2019
Secured Term Loan  
Schedule of Future Principal Maturities of Secured Term Loan
As of September 30, 2019, the future principal maturities of our Secured Term Loan for each of the next five years are as follows (in thousands):
Year ended December 31,
 
2022
$
9,615

2023
9,615

2024
9,615

Thereafter
33,655

Total
$
62,500
HealthCare Royalty Partners and its Affiliates (“HCR”)  
Schedule of Payment Obligations
Our payment obligations for HCR royalty-based debt are as follows (in thousands):
 
September 30, 2019
 
December 31, 2018
Total repayment obligations
$
290,550

 
$
290,550

Less: interests to be accreted in future periods
(109,060
)
 
(125,851
)
Less: payments made
(6,006
)
 
(816
)
Carrying value of long term royalty-based debt
175,484

 
163,883

Less: current portion of royalties
(18,302
)
 
(8,627
)
Non-current portion of long term royalty-based debt
$
157,182

 
$
155,256
Bristol-Myers Squibb Company ("BMS") and Pfizer Inc. ("Pfizer")  
Schedule of Payment Obligations
Our payment obligations for BMS and Pfizer Promissory Notes are as follows (in thousands):
 
September 30, 2019
 
December 31, 2018
Total repayment obligations
$
62,500

 
$
62,500

Less: interests to be accreted in future periods
(6,191
)
 
(8,643
)
Less: payments made
(3,564
)
 
(497
)
Carrying value of notes payable
52,745

 
53,360

Less: current portion of royalties
(10,817
)
 
(5,062
)
Non-current portion of notes payable
$
41,928

 
$
48,298